Patients’ risk distribution at the time of diagnosis
| Overall | Group A | Group B | Group C | p-value | |
| Patients n | 181 | 96 | 54 | 31 | |
| ERS/ESC score, n (%) | |||||
| Low | 27 (14.9) | 15 (15.6) | 6 (11.1) | 6 (19.3) | NS |
| Intermediate | 130 (71.8) | 70 (72.9) | 41 (75.9) | 19 (61.4) | |
| High | 24 (13.3) | 11 (11.5) | 7 (13.0) | 6 (19.3) | |
| REVEAL 2.0, n (%) | |||||
| Low (<7) | 19 (10.5) | 9 (9.4) | 7 (13.0) | 3 (9.7) | NS |
| Intermediate (7–8) | 100 (55.2) | 56 (58.3) | 27 (50.0) | 17 (54.8) | |
| High (>8) | 62 (34.3) | 31 (32.3) | 20 (37.0) | 11 (35.5) | |
Group A: patients without cardiovascular comorbidities; Group B: patients with one cardiovascular comorbidity; Group C: patients with at least two cardiovascular comorbidities. Results are expressed as n (%). ERS/ESC: European Respiratory Society/European Society of Cardiology; ns: nonsignificant.